These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: High-sensitivity C-reactive protein: a novel cardiovascular risk predictor in type 2 diabetics with normal lipid profile.
    Author: Asegaonkar SB, Marathe A, Tekade ML, Cherekar L, Bavikar J, Bardapurkar J, Ajay R.
    Journal: J Diabetes Complications; 2011; 25(6):368-70. PubMed ID: 22055258.
    Abstract:
    BACKGROUND: India is the diabetic capital of the world. Coronary heart disease is a major cause of morbidity and mortality among diabetics. Type 2 diabetes mellitus and atherosclerosis are complex diseases sharing common antecedents like inflammation. High-sensitivity C-reactive protein (hs-CRP), an acute phase reactant protein, is a proinflammatory atherogenic circulating marker which can prove to be an independent cardiac risk predictor. AIM: The aim of the present study was to evaluate the role of hs-CRP as an independent cardiovascular risk marker among Indians with type 2 diabetes with normal lipid profile. SETTINGS AND DESIGN: This was a case control study including 60 type 2 diabetics with normal lipid profile and 60 age- and sex-matched healthy controls. MATERIALS AND METHODS: Twelve-hour fasting blood samples were collected from all the participants. Serum was assayed for hs-CRP and lipid profile. STATISTICAL ANALYSIS: Results were analyzed by unpaired t test. RESULTS: We found elevated hs-CRP levels (4.8 ± 0.2, P < .0001) among cases compared to controls (0.9 ± 0.1). According to hs-CRP levels, seven cases were in the low-risk (< 1 mg/l), 32 in the moderate-risk (1-3 mg/l), and 21 in the high-risk (3-10 mg/l) group with mean values of hs-CRP of 0.7 ± 0.2, 1.75 ± 0.7, and 5.8 ± 1.4, respectively. Relative risk was 4.75 with odds ratio of 10.23 (95% confidence interval 8.8-11.23). CONCLUSION: The study suggests that hs-CRP is an independent cardiac risk predictor even with normal lipid profile and can help measure additional risk. The American Heart Association stated that patients in the intermediate- and high-risk group may benefit from therapeutic lifestyle change and that cardiovascular event may be prevented.
    [Abstract] [Full Text] [Related] [New Search]